These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17301968)

  • 1. Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
    Bulchandani D; Nachnani J; Belt R; Hinton S
    Am J Hematol; 2007 Jul; 82(7):650-1. PubMed ID: 17301968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes?
    Felderbauer P; Ritter PR; Mattern D; Schmitz F; Bulut K; Ansorge N; Schmitt-Graeff A; Schmidt WE; Baier JE
    Eur J Haematol; 2004 Jun; 72(6):451-4. PubMed ID: 15128427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired pure megakaryocytic aplasia in course of hepatitis in a patient with immune thrombocytopenic purpura.
    Iannelli S; Petrini MT
    Acta Haematol; 1984; 72(5):355-6. PubMed ID: 6441418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired pure megakaryocytic aplasia successfully treated with cyclosporine.
    Omri HE; Ibrahim F; Taha RY; Negm RH; Khinji AA; Yassin M; Hijji IA; Ayoubi HE; Baden H
    Turk J Haematol; 2010 Dec; 27(4):289-93. PubMed ID: 27263744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.
    Bakrac M; Jurisic V; Kostic T; Popovic V; Pekic S; Kraguljac N; Colovic M
    J Clin Pathol; 2007 Jun; 60(6):717-20. PubMed ID: 17220208
    [No Abstract]   [Full Text] [Related]  

  • 6. Depressive disorder associated with mycophenolate mofetil.
    Draper HM
    Pharmacotherapy; 2008 Jan; 28(1):136-9. PubMed ID: 18154484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
    Arcasoy MO; Chao NJ
    Am J Hematol; 2005 Feb; 78(2):161-3. PubMed ID: 15682416
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
    Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case reports: nodular vasculitis responsive to mycophenolate mofetil.
    Taverna JA; Radfar A; Pentland A; Poggioli G; Demierre MF
    J Drugs Dermatol; 2006; 5(10):992-3. PubMed ID: 17373149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Electron microscopy findings in the bone marrow of chronic megakaryocytic-granulocytic myelosis].
    Thiele J; Vykoupil KF; Georgii A; Ballard AC
    Verh Dtsch Ges Pathol; 1975; 59():480. PubMed ID: 1217091
    [No Abstract]   [Full Text] [Related]  

  • 17. Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.
    Vrisekoop N; Sankatsing SU; Jansen CA; Roos MT; Otto SA; Schuitemaker H; Lange JM; Prins JM; Miedema F
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):991-6. PubMed ID: 16379601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolic Acid reaches therapeutic levels whereas mycophenolate mofetil does not.
    Vilalta Casas R; Vila López A; Nieto Rey JL; Lara Moctezuma LE; Madrid Aris A; Quintana Montero M; Pou Clave L
    Transplant Proc; 2006 Oct; 38(8):2400-1. PubMed ID: 17097947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
    Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
    Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V; Libetta C; Giuliano MG; Adamo G; Dal Canton A
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.